(DumbMoney)

Explore the latest updates and key analyses on companies, markets, and industry trends.


Study into eBalance® Device's Impact on Neuronal Mitochondrial Function Announced by StimCell Energetics Inc.

StimCell Energetics Inc. (STME) | December 2, 2025

By Noah Edwards

image

StimCell Energetics Inc. announced a collaboration with St. Boniface Hospital Albrechtsen Research Centre to study the effects of eBalance® device on mitochondrial function in cultured sensory neurons.

Dr. Paul Fernyhough will lead the research team in conducting experiments to evaluate eBalance® stimulation's influence on cellular energy production by mitochondria.

The study will involve assessing oxygen consumption rates, ATP production, glycolysis, and enzyme activities to understand the potential therapeutic applications of the technology.

Collaboration with St. Boniface Hospital

Partnering with a renowned research center to explore the impact of eBalance® device on mitochondrial function.

Research on Cellular Energy Production

Focused on evaluating how eBalance® stimulation affects key aspects of energy production in cells.

Leading Expertise

Dr. Paul Fernyhough, an expert in neuronal bioenergetics, is leading the research team for in-depth analysis.

  • The collaboration signifies a significant advancement for StimCell Energetics Inc. in understanding the potential of their technology in enhancing mitochondrial performance.
  • The research outcomes may pave the way for new therapeutic applications in neurology and related fields, emphasizing the Company's commitment to evidence-based innovation.

The study's findings are anticipated to provide valuable insights into the biological effects of eBalance® stimulation on cellular energy production, potentially opening new avenues for therapeutic developments in healthcare.